{
  "id": 483761,
  "title": "Kaplan Fox Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Who Suffered Losses to a Securities Class Action – Deadline is September 28, 2026",
  "url": "https://urgent.news/2026/08/10/kaplan-fox-alerts-capricor-therapeutics-inc-nasdaq-capr-investors-who",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-10T15:18:20.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/kaplan-fox-alerts-capricor-therapeutics-inc-nasdaq-capr-investors-who-suffered-losses-to-a-securities-class-action-deadline-is-september-28-2026"
  },
  "original_language": "en",
  "account": null,
  "summary": "NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) — Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (the “Class Period”). CLICK […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}